September 20, 2024
By Tim Welter | Clarie Caherty | Jason Blessing
Over the last decade, new technologies like artificial intelligence and advanced sensors have drastically changed and accelerated the field of biotechnology. At the same time, a renewed national interest in space exploration is driving advances in space medicine, which carry positive spillover effects for terrestrial medicine and other biotechnology capabilities. The bioeconomy—both biotechnology and biomanufacturing—is an important strategic asset to the future of American prosperity.
On August 20th, 2024, the Potomac Institute for Policy Studies convened a panel of experts to explore intersections of biotechnology, biomanufacturing, and national security consequential to America’s competitive posture. The panel discussed potential opportunities, risks, policy implications, and recommendations for the United States to prevent, deter, and mitigate challenges as well as maintain and increase its competitive advantage on the global stage.
